You searched for "research"
Glaucoma UK announces £100,000 Health and Social Care Professionals Award for 2024
Glaucoma UK is pleased to announce that applications for its Health and Social Care Professionals Research Award are now open.Blindness from some inherited eye diseases may be caused by gut bacteria
Sight loss in certain inherited eye diseases may be caused by gut bacteria, and is potentially treatable by antimicrobials, finds a new study in mice co-led by a UCL and Moorfields researcher.Broadening horizons in ophthalmology: crafting a varied elective experience
24 January 2024
| Rishikesh Gandhewar
|
EYE - General
The elective period for medical students is a unique opportunity to immerse oneself in a field of interest. For students interested in ophthalmology, this can offer a dedicated experience for what can otherwise be quite limited through undergraduate rotations. Alongside...
Doing a systematic review: a users’ guide for foundation doctors
1 June 2022
| Thomas McNally
|
EYE - General
Research is increasingly important for junior doctors and systematic reviews (SRs) are a great place to start. Carrying out an SR can help a doctor demonstrate commitment to a specialty, develop research skills and get results quickly. This article aims...
Planes, trams, and auditoriums: Beware predatory conferencing
4 December 2024
| Rod McNeil
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Predatory open-access journals and predatory conferences are considered the two main areas of predatory infiltration in academic medicine that are of growing concern [1–7]. Unsolicited publishing requests from potentially predatory publishers occur frequently among faculty in ophthalmology [8]. Predatory conferencing...
Quality of life concerns after uveal melanoma diagnosis
The authors sought to investigate factors associated with Quality Of Life (QOL) after initial diagnosis of uveal melanoma (UM) using prospectively collected data between September 2011-May 2016. They included 201 participants referred for radiotherapy after UM diagnosis by an ophthalmic...Inherited retinal disorders now the leading cause of blindness
1 April 2014
| Thomas O'Neill
|
EYE - Vitreo-Retinal
The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...
Esme’s Umbrella announces the world’s first Charles Bonnet Syndrome Essay Prizes
20 February 2023
| Judith Potts
Esme’s Umbrella (www.charlesbonnetsyndrome) has just announced the world’s first Charles Bonnet Syndrome Essay Prizes.
Moorfields Eye Charity appoints Dr Louise Wood CBE as new chair
3 June 2024
|
Louise Wood, Moorfields, Industry, infrastructure, charity, hospital, grants, Appointments
Dr Louise Wood CBE has been appointed as Moorfields Eye Charity’s new chair and will succeed Mervyn Walker when he steps down from the role in July 2024.
First treatment for late-stage dry AMD rejected by UK drug regulator
Leading sight loss charity the Macular Society has responded to the decision not to approve the first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration. The decision is a significant setback for those affected by...EQUALeyes: Illuminating insights into using health data, AI and inclusion
24 October 2024
Reflecting the Bloomsbury Festival theme of Human.Kind, and current public conversations on the benefits and potential threats of AI, we bring together leaders in the field of healthcare AI to discuss key issues, with a special focus on eyes.
Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis
22 August 2023
|
moorfields, Parkinson's disease, Siegfried Wagner, Pearse Keane, UCL Institute of Ophthalmology, early detection
A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation.
